Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Colloids (Blood Plasma) Market Research Report 2025

Global Colloids (Blood Plasma) Market Research Report 2025

Industry: Pharma & Healthcare

Published Date: 2025-01-16

Pages: 115 Pages

Report ld: 3470346

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Colloids (Blood Plasma) Market Size(US$)

CAGR 2025-2031

-2.5%

Market Size,2031

USD 325

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 378 million

Market Forecast in 2031(Value)

US$ 325 million

CAGR

-2.5%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Colloids (Blood Plasma) was valued at US$ 387 million in the year 2024 and is projected to reach a revised size of US$ 325 million by 2031, growing at a CAGR of -2.5% during the forecast period.

Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.

Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.

North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.

The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Colloids (Blood Plasma), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colloids (Blood Plasma).

The Colloids (Blood Plasma) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Colloids (Blood Plasma) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Colloids (Blood Plasma) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

CSL Behring

Baxter

Grifols

Octapharma

Kedrion

Shanghai Raas

CTBB

Hualan Bio

Rongsheng Pharmaceutical

Boya Rongsheng

B. Braun Medical

Fresenius Kabi

HOSPIRA

Axa parenterals

Fresenius Kabi (China)

CR Double-Crane

Kelun Group

Shandong Qidu Pharmaceutical

Shandong Hualu Pharmaceutical

Minsheng Pharma

Kanglepharm

Segment by Type

Natural Type Colloids (Blood Plasma)

Synthetic Type Colloids (Blood Plasma)

Segment by Application

Extensive Burns

Massive Blood or Plasma Loss

Hypovolemic Shock

Others

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Colloids (Blood Plasma) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Colloids (Blood Plasma) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Colloids (Blood Plasma) Market Overview

1.1 Product Definition

1.2 Colloids (Blood Plasma) by Type

1.2.1 Global Colloids (Blood Plasma) Market Value Comparison by Type (2024 VS 2031)

1.2.2 Natural Type Colloids (Blood Plasma)

1.2.3 Synthetic Type Colloids (Blood Plasma)

1.3 Colloids (Blood Plasma) by Application

1.3.1 Global Colloids (Blood Plasma) Market Value by Application (2024 VS 2031)

1.3.2 Extensive Burns

1.3.3 Massive Blood or Plasma Loss

1.3.4 Hypovolemic Shock

1.3.5 Others

1.4 Global Colloids (Blood Plasma) Market Size Estimates and Forecasts

1.4.1 Global Colloids (Blood Plasma) Revenue 2020-2031

1.4.2 Global Colloids (Blood Plasma) Sales 2020-2031

1.4.3 Global Colloids (Blood Plasma) Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Colloids (Blood Plasma) Market Competition by Manufacturers

2.1 Global Colloids (Blood Plasma) Sales Market Share by Manufacturers (2020-2025)

2.2 Global Colloids (Blood Plasma) Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Colloids (Blood Plasma) Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Colloids (Blood Plasma), Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Colloids (Blood Plasma), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Colloids (Blood Plasma), Product Type & Application

2.7 Global Key Manufacturers of Colloids (Blood Plasma), Date of Enter into This Industry

2.8 Global Colloids (Blood Plasma) Market Competitive Situation and Trends

2.8.1 Global Colloids (Blood Plasma) Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Colloids (Blood Plasma) Players Market Share by Revenue

2.8.3 Global Colloids (Blood Plasma) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Colloids (Blood Plasma) Market Scenario by Region

3.1 Global Colloids (Blood Plasma) Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Colloids (Blood Plasma) Sales by Region: 2020-2031

3.2.1 Global Colloids (Blood Plasma) Sales by Region: 2020-2025

3.2.2 Global Colloids (Blood Plasma) Sales by Region: 2026-2031

3.3 Global Colloids (Blood Plasma) Revenue by Region: 2020-2031

3.3.1 Global Colloids (Blood Plasma) Revenue by Region: 2020-2025

3.3.2 Global Colloids (Blood Plasma) Revenue by Region: 2026-2031

3.4 North America Colloids (Blood Plasma) Market Facts & Figures by Country

3.4.1 North America Colloids (Blood Plasma) Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Colloids (Blood Plasma) Sales by Country (2020-2031)

3.4.3 North America Colloids (Blood Plasma) Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Colloids (Blood Plasma) Market Facts & Figures by Country

3.5.1 Europe Colloids (Blood Plasma) Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Colloids (Blood Plasma) Sales by Country (2020-2031)

3.5.3 Europe Colloids (Blood Plasma) Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Colloids (Blood Plasma) Market Facts & Figures by Region

3.6.1 Asia Pacific Colloids (Blood Plasma) Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Colloids (Blood Plasma) Sales by Region (2020-2031)

3.6.3 Asia Pacific Colloids (Blood Plasma) Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Colloids (Blood Plasma) Market Facts & Figures by Country

3.7.1 Latin America Colloids (Blood Plasma) Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Colloids (Blood Plasma) Sales by Country (2020-2031)

3.7.3 Latin America Colloids (Blood Plasma) Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Colloids (Blood Plasma) Market Facts & Figures by Country

3.8.1 Middle East and Africa Colloids (Blood Plasma) Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Colloids (Blood Plasma) Sales by Country (2020-2031)

3.8.3 Middle East and Africa Colloids (Blood Plasma) Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Colloids (Blood Plasma) Sales by Type (2020-2031)

4.1.1 Global Colloids (Blood Plasma) Sales by Type (2020-2025)

4.1.2 Global Colloids (Blood Plasma) Sales by Type (2026-2031)

4.1.3 Global Colloids (Blood Plasma) Sales Market Share by Type (2020-2031)

4.2 Global Colloids (Blood Plasma) Revenue by Type (2020-2031)

4.2.1 Global Colloids (Blood Plasma) Revenue by Type (2020-2025)

4.2.2 Global Colloids (Blood Plasma) Revenue by Type (2026-2031)

4.2.3 Global Colloids (Blood Plasma) Revenue Market Share by Type (2020-2031)

4.3 Global Colloids (Blood Plasma) Price by Type (2020-2031)

5 Segment by Application

5.1 Global Colloids (Blood Plasma) Sales by Application (2020-2031)

5.1.1 Global Colloids (Blood Plasma) Sales by Application (2020-2025)

5.1.2 Global Colloids (Blood Plasma) Sales by Application (2026-2031)

5.1.3 Global Colloids (Blood Plasma) Sales Market Share by Application (2020-2031)

5.2 Global Colloids (Blood Plasma) Revenue by Application (2020-2031)

5.2.1 Global Colloids (Blood Plasma) Revenue by Application (2020-2025)

5.2.2 Global Colloids (Blood Plasma) Revenue by Application (2026-2031)

5.2.3 Global Colloids (Blood Plasma) Revenue Market Share by Application (2020-2031)

5.3 Global Colloids (Blood Plasma) Price by Application (2020-2031)

6 Key Companies Profiled

6.1 CSL Behring

6.1.1 CSL Behring Company Information

6.1.2 CSL Behring Description and Business Overview

6.1.3 CSL Behring Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.1.4 CSL Behring Colloids (Blood Plasma) Product Portfolio

6.1.5 CSL Behring Recent Developments/Updates

6.2 Baxter

6.2.1 Baxter Company Information

6.2.2 Baxter Description and Business Overview

6.2.3 Baxter Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Baxter Colloids (Blood Plasma) Product Portfolio

6.2.5 Baxter Recent Developments/Updates

6.3 Grifols

6.3.1 Grifols Company Information

6.3.2 Grifols Description and Business Overview

6.3.3 Grifols Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Grifols Colloids (Blood Plasma) Product Portfolio

6.3.5 Grifols Recent Developments/Updates

6.4 Octapharma

6.4.1 Octapharma Company Information

6.4.2 Octapharma Description and Business Overview

6.4.3 Octapharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Octapharma Colloids (Blood Plasma) Product Portfolio

6.4.5 Octapharma Recent Developments/Updates

6.5 Kedrion

6.5.1 Kedrion Company Information

6.5.2 Kedrion Description and Business Overview

6.5.3 Kedrion Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Kedrion Colloids (Blood Plasma) Product Portfolio

6.5.5 Kedrion Recent Developments/Updates

6.6 Shanghai Raas

6.6.1 Shanghai Raas Company Information

6.6.2 Shanghai Raas Description and Business Overview

6.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Shanghai Raas Colloids (Blood Plasma) Product Portfolio

6.6.5 Shanghai Raas Recent Developments/Updates

6.7 CTBB

6.7.1 CTBB Company Information

6.7.2 CTBB Description and Business Overview

6.7.3 CTBB Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.7.4 CTBB Colloids (Blood Plasma) Product Portfolio

6.7.5 CTBB Recent Developments/Updates

6.8 Hualan Bio

6.8.1 Hualan Bio Company Information

6.8.2 Hualan Bio Description and Business Overview

6.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Hualan Bio Colloids (Blood Plasma) Product Portfolio

6.8.5 Hualan Bio Recent Developments/Updates

6.9 Rongsheng Pharmaceutical

6.9.1 Rongsheng Pharmaceutical Company Information

6.9.2 Rongsheng Pharmaceutical Description and Business Overview

6.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Portfolio

6.9.5 Rongsheng Pharmaceutical Recent Developments/Updates

6.10 Boya Rongsheng

6.10.1 Boya Rongsheng Company Information

6.10.2 Boya Rongsheng Description and Business Overview

6.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Boya Rongsheng Colloids (Blood Plasma) Product Portfolio

6.10.5 Boya Rongsheng Recent Developments/Updates

6.11 B. Braun Medical

6.11.1 B. Braun Medical Company Information

6.11.2 B. Braun Medical Description and Business Overview

6.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.11.4 B. Braun Medical Colloids (Blood Plasma) Product Portfolio

6.11.5 B. Braun Medical Recent Developments/Updates

6.12 Fresenius Kabi

6.12.1 Fresenius Kabi Company Information

6.12.2 Fresenius Kabi Description and Business Overview

6.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Fresenius Kabi Colloids (Blood Plasma) Product Portfolio

6.12.5 Fresenius Kabi Recent Developments/Updates

6.13 HOSPIRA

6.13.1 HOSPIRA Company Information

6.13.2 HOSPIRA Description and Business Overview

6.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.13.4 HOSPIRA Colloids (Blood Plasma) Product Portfolio

6.13.5 HOSPIRA Recent Developments/Updates

6.14 Axa parenterals

6.14.1 Axa parenterals Company Information

6.14.2 Axa parenterals Description and Business Overview

6.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Axa parenterals Colloids (Blood Plasma) Product Portfolio

6.14.5 Axa parenterals Recent Developments/Updates

6.15 Fresenius Kabi (China)

6.15.1 Fresenius Kabi (China) Company Information

6.15.2 Fresenius Kabi (China) Description and Business Overview

6.15.3 Fresenius Kabi (China) Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Fresenius Kabi (China) Colloids (Blood Plasma) Product Portfolio

6.15.5 Fresenius Kabi (China) Recent Developments/Updates

6.16 CR Double-Crane

6.16.1 CR Double-Crane Company Information

6.16.2 CR Double-Crane Description and Business Overview

6.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.16.4 CR Double-Crane Colloids (Blood Plasma) Product Portfolio

6.16.5 CR Double-Crane Recent Developments/Updates

6.17 Kelun Group

6.17.1 Kelun Group Company Information

6.17.2 Kelun Group Description and Business Overview

6.17.3 Kelun Group Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Kelun Group Colloids (Blood Plasma) Product Portfolio

6.17.5 Kelun Group Recent Developments/Updates

6.18 Shandong Qidu Pharmaceutical

6.18.1 Shandong Qidu Pharmaceutical Company Information

6.18.2 Shandong Qidu Pharmaceutical Description and Business Overview

6.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Portfolio

6.18.5 Shandong Qidu Pharmaceutical Recent Developments/Updates

6.19 Shandong Hualu Pharmaceutical

6.19.1 Shandong Hualu Pharmaceutical Company Information

6.19.2 Shandong Hualu Pharmaceutical Description and Business Overview

6.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Portfolio

6.19.5 Shandong Hualu Pharmaceutical Recent Developments/Updates

6.20 Minsheng Pharma

6.20.1 Minsheng Pharma Company Information

6.20.2 Minsheng Pharma Description and Business Overview

6.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.20.4 Minsheng Pharma Colloids (Blood Plasma) Product Portfolio

6.20.5 Minsheng Pharma Recent Developments/Updates

6.21 Kanglepharm

6.21.1 Kanglepharm Company Information

6.21.2 Kanglepharm Description and Business Overview

6.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)

6.21.4 Kanglepharm Colloids (Blood Plasma) Product Portfolio

6.21.5 Kanglepharm Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Colloids (Blood Plasma) Industry Chain Analysis

7.2 Colloids (Blood Plasma) Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Colloids (Blood Plasma) Production Mode & Process Analysis

7.4 Colloids (Blood Plasma) Sales and Marketing

7.4.1 Colloids (Blood Plasma) Sales Channels

7.4.2 Colloids (Blood Plasma) Distributors

7.5 Colloids (Blood Plasma) Customer Analysis

8 Colloids (Blood Plasma) Market Dynamics

8.1 Colloids (Blood Plasma) Industry Trends

8.2 Colloids (Blood Plasma) Market Drivers

8.3 Colloids (Blood Plasma) Market Challenges

8.4 Colloids (Blood Plasma) Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Colloids (Blood Plasma) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Colloids (Blood Plasma) Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Colloids (Blood Plasma) Market Competitive Situation by Manufacturers in 2024

Table 4. Global Colloids (Blood Plasma) Sales (MT) of Key Manufacturers (2020-2025)

Table 5. Global Colloids (Blood Plasma) Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Colloids (Blood Plasma) Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Colloids (Blood Plasma) Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Colloids (Blood Plasma) Average Price (USD/Kg) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Colloids (Blood Plasma), Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Colloids (Blood Plasma), Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Colloids (Blood Plasma), Product Type & Application

Table 12. Global Key Manufacturers of Colloids (Blood Plasma), Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Colloids (Blood Plasma) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colloids (Blood Plasma) as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Colloids (Blood Plasma) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Colloids (Blood Plasma) Sales by Region (2020-2025) & (MT)

Table 18. Global Colloids (Blood Plasma) Sales Market Share by Region (2020-2025)

Table 19. Global Colloids (Blood Plasma) Sales by Region (2026-2031) & (MT)

Table 20. Global Colloids (Blood Plasma) Sales Market Share by Region (2026-2031)

Table 21. Global Colloids (Blood Plasma) Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Colloids (Blood Plasma) Revenue Market Share by Region (2020-2025)

Table 23. Global Colloids (Blood Plasma) Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Colloids (Blood Plasma) Revenue Market Share by Region (2026-2031)

Table 25. North America Colloids (Blood Plasma) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Colloids (Blood Plasma) Sales by Country (2020-2025) & (MT)

Table 27. North America Colloids (Blood Plasma) Sales by Country (2026-2031) & (MT)

Table 28. North America Colloids (Blood Plasma) Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Colloids (Blood Plasma) Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Colloids (Blood Plasma) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Colloids (Blood Plasma) Sales by Country (2020-2025) & (MT)

Table 32. Europe Colloids (Blood Plasma) Sales by Country (2026-2031) & (MT)

Table 33. Europe Colloids (Blood Plasma) Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Colloids (Blood Plasma) Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Colloids (Blood Plasma) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Colloids (Blood Plasma) Sales by Region (2020-2025) & (MT)

Table 37. Asia Pacific Colloids (Blood Plasma) Sales by Region (2026-2031) & (MT)

Table 38. Asia Pacific Colloids (Blood Plasma) Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Colloids (Blood Plasma) Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Colloids (Blood Plasma) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Colloids (Blood Plasma) Sales by Country (2020-2025) & (MT)

Table 42. Latin America Colloids (Blood Plasma) Sales by Country (2026-2031) & (MT)

Table 43. Latin America Colloids (Blood Plasma) Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Colloids (Blood Plasma) Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Colloids (Blood Plasma) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Colloids (Blood Plasma) Sales by Country (2020-2025) & (MT)

Table 47. Middle East and Africa Colloids (Blood Plasma) Sales by Country (2026-2031) & (MT)

Table 48. Middle East and Africa Colloids (Blood Plasma) Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Colloids (Blood Plasma) Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Colloids (Blood Plasma) Sales (MT) by Type (2020-2025)

Table 51. Global Colloids (Blood Plasma) Sales (MT) by Type (2026-2031)

Table 52. Global Colloids (Blood Plasma) Sales Market Share by Type (2020-2025)

Table 53. Global Colloids (Blood Plasma) Sales Market Share by Type (2026-2031)

Table 54. Global Colloids (Blood Plasma) Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Colloids (Blood Plasma) Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Colloids (Blood Plasma) Revenue Market Share by Type (2020-2025)

Table 57. Global Colloids (Blood Plasma) Revenue Market Share by Type (2026-2031)

Table 58. Global Colloids (Blood Plasma) Price (USD/Kg) by Type (2020-2025)

Table 59. Global Colloids (Blood Plasma) Price (USD/Kg) by Type (2026-2031)

Table 60. Global Colloids (Blood Plasma) Sales (MT) by Application (2020-2025)

Table 61. Global Colloids (Blood Plasma) Sales (MT) by Application (2026-2031)

Table 62. Global Colloids (Blood Plasma) Sales Market Share by Application (2020-2025)

Table 63. Global Colloids (Blood Plasma) Sales Market Share by Application (2026-2031)

Table 64. Global Colloids (Blood Plasma) Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Colloids (Blood Plasma) Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Colloids (Blood Plasma) Revenue Market Share by Application (2020-2025)

Table 67. Global Colloids (Blood Plasma) Revenue Market Share by Application (2026-2031)

Table 68. Global Colloids (Blood Plasma) Price (USD/Kg) by Application (2020-2025)

Table 69. Global Colloids (Blood Plasma) Price (USD/Kg) by Application (2026-2031)

Table 70. CSL Behring Company Information

Table 71. CSL Behring Description and Business Overview

Table 72. CSL Behring Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 73. CSL Behring Colloids (Blood Plasma) Product

Table 74. CSL Behring Recent Developments/Updates

Table 75. Baxter Company Information

Table 76. Baxter Description and Business Overview

Table 77. Baxter Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 78. Baxter Colloids (Blood Plasma) Product

Table 79. Baxter Recent Developments/Updates

Table 80. Grifols Company Information

Table 81. Grifols Description and Business Overview

Table 82. Grifols Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 83. Grifols Colloids (Blood Plasma) Product

Table 84. Grifols Recent Developments/Updates

Table 85. Octapharma Company Information

Table 86. Octapharma Description and Business Overview

Table 87. Octapharma Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 88. Octapharma Colloids (Blood Plasma) Product

Table 89. Octapharma Recent Developments/Updates

Table 90. Kedrion Company Information

Table 91. Kedrion Description and Business Overview

Table 92. Kedrion Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 93. Kedrion Colloids (Blood Plasma) Product

Table 94. Kedrion Recent Developments/Updates

Table 95. Shanghai Raas Company Information

Table 96. Shanghai Raas Description and Business Overview

Table 97. Shanghai Raas Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 98. Shanghai Raas Colloids (Blood Plasma) Product

Table 99. Shanghai Raas Recent Developments/Updates

Table 100. CTBB Company Information

Table 101. CTBB Description and Business Overview

Table 102. CTBB Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 103. CTBB Colloids (Blood Plasma) Product

Table 104. CTBB Recent Developments/Updates

Table 105. Hualan Bio Company Information

Table 106. Hualan Bio Description and Business Overview

Table 107. Hualan Bio Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 108. Hualan Bio Colloids (Blood Plasma) Product

Table 109. Hualan Bio Recent Developments/Updates

Table 110. Rongsheng Pharmaceutical Company Information

Table 111. Rongsheng Pharmaceutical Description and Business Overview

Table 112. Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 113. Rongsheng Pharmaceutical Colloids (Blood Plasma) Product

Table 114. Rongsheng Pharmaceutical Recent Developments/Updates

Table 115. Boya Rongsheng Company Information

Table 116. Boya Rongsheng Description and Business Overview

Table 117. Boya Rongsheng Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 118. Boya Rongsheng Colloids (Blood Plasma) Product

Table 119. Boya Rongsheng Recent Developments/Updates

Table 120. B. Braun Medical Company Information

Table 121. B. Braun Medical Description and Business Overview

Table 122. B. Braun Medical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 123. B. Braun Medical Colloids (Blood Plasma) Product

Table 124. B. Braun Medical Recent Developments/Updates

Table 125. Fresenius Kabi Company Information

Table 126. Fresenius Kabi Description and Business Overview

Table 127. Fresenius Kabi Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 128. Fresenius Kabi Colloids (Blood Plasma) Product

Table 129. Fresenius Kabi Recent Developments/Updates

Table 130. HOSPIRA Company Information

Table 131. HOSPIRA Description and Business Overview

Table 132. HOSPIRA Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 133. HOSPIRA Colloids (Blood Plasma) Product

Table 134. HOSPIRA Recent Developments/Updates

Table 135. Axa parenterals Company Information

Table 136. Axa parenterals Description and Business Overview

Table 137. Axa parenterals Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 138. Axa parenterals Colloids (Blood Plasma) Product

Table 139. Axa parenterals Recent Developments/Updates

Table 140. Fresenius Kabi (China) Company Information

Table 141. Fresenius Kabi (China) Description and Business Overview

Table 142. Fresenius Kabi (China) Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 143. Fresenius Kabi (China) Colloids (Blood Plasma) Product

Table 144. Fresenius Kabi (China) Recent Developments/Updates

Table 145. CR Double-Crane Company Information

Table 146. CR Double-Crane Description and Business Overview

Table 147. CR Double-Crane Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 148. CR Double-Crane Colloids (Blood Plasma) Product

Table 149. CR Double-Crane Recent Developments/Updates

Table 150. Kelun Group Company Information

Table 151. Kelun Group Description and Business Overview

Table 152. Kelun Group Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 153. Kelun Group Colloids (Blood Plasma) Product

Table 154. Kelun Group Recent Developments/Updates

Table 155. Shandong Qidu Pharmaceutical Company Information

Table 156. Shandong Qidu Pharmaceutical Description and Business Overview

Table 157. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 158. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product

Table 159. Shandong Qidu Pharmaceutical Recent Developments/Updates

Table 160. Shandong Hualu Pharmaceutical Company Information

Table 161. Shandong Hualu Pharmaceutical Description and Business Overview

Table 162. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 163. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product

Table 164. Shandong Hualu Pharmaceutical Recent Developments/Updates

Table 165. Minsheng Pharma Company Information

Table 166. Minsheng Pharma Description and Business Overview

Table 167. Minsheng Pharma Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 168. Minsheng Pharma Colloids (Blood Plasma) Product

Table 169. Minsheng Pharma Recent Developments/Updates

Table 170. Kanglepharm Company Information

Table 171. Kanglepharm Description and Business Overview

Table 172. Kanglepharm Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 173. Kanglepharm Colloids (Blood Plasma) Product

Table 174. Kanglepharm Recent Developments/Updates

Table 175. Key Raw Materials Lists

Table 176. Raw Materials Key Suppliers Lists

Table 177. Colloids (Blood Plasma) Distributors List

Table 178. Colloids (Blood Plasma) Customers List

Table 179. Colloids (Blood Plasma) Market Trends

Table 180. Colloids (Blood Plasma) Market Drivers

Table 181. Colloids (Blood Plasma) Market Challenges

Table 182. Colloids (Blood Plasma) Market Restraints

Table 183. Research Programs/Design for This Report

Table 184. Key Data Information from Secondary Sources

Table 185. Key Data Information from Primary Sources

Table 186. Authors List of This Report

List of Figures

Figure 1. Product Picture of Colloids (Blood Plasma)

Figure 2. Global Colloids (Blood Plasma) Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Colloids (Blood Plasma) Market Share by Type: 2024 & 2031

Figure 4. Natural Type Colloids (Blood Plasma) Product Picture

Figure 5. Synthetic Type Colloids (Blood Plasma) Product Picture

Figure 6. Global Colloids (Blood Plasma) Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Colloids (Blood Plasma) Market Share by Application: 2024 & 2031

Figure 8. Extensive Burns

Figure 9. Massive Blood or Plasma Loss

Figure 10. Hypovolemic Shock

Figure 11. Others

Figure 12. Global Colloids (Blood Plasma) Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Colloids (Blood Plasma) Market Size (2020-2031) & (US$ Million)

Figure 14. Global Colloids (Blood Plasma) Sales (2020-2031) & (MT)

Figure 15. Global Colloids (Blood Plasma) Average Price (USD/Kg) & (2020-2031)

Figure 16. Colloids (Blood Plasma) Report Years Considered

Figure 17. Colloids (Blood Plasma) Sales Share by Manufacturers in 2024

Figure 18. Global Colloids (Blood Plasma) Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Colloids (Blood Plasma) Players: Market Share by Revenue in Colloids (Blood Plasma) in 2024

Figure 20. Colloids (Blood Plasma) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Colloids (Blood Plasma) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Colloids (Blood Plasma) Sales Market Share by Country (2020-2031)

Figure 23. North America Colloids (Blood Plasma) Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Colloids (Blood Plasma) Sales Market Share by Country (2020-2031)

Figure 27. Europe Colloids (Blood Plasma) Revenue Market Share by Country (2020-2031)

Figure 28. Germany Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Colloids (Blood Plasma) Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Colloids (Blood Plasma) Revenue Market Share by Region (2020-2031)

Figure 35. China Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Colloids (Blood Plasma) Sales Market Share by Country (2020-2031)

Figure 46. Latin America Colloids (Blood Plasma) Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Colloids (Blood Plasma) Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Colloids (Blood Plasma) Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. U.A.E Colloids (Blood Plasma) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Colloids (Blood Plasma) by Type (2020-2031)

Figure 56. Global Revenue Market Share of Colloids (Blood Plasma) by Type (2020-2031)

Figure 57. Global Colloids (Blood Plasma) Price (USD/Kg) by Type (2020-2031)

Figure 58. Global Sales Market Share of Colloids (Blood Plasma) by Application (2020-2031)

Figure 59. Global Revenue Market Share of Colloids (Blood Plasma) by Application (2020-2031)

Figure 60. Global Colloids (Blood Plasma) Price (USD/Kg) by Application (2020-2031)

Figure 61. Colloids (Blood Plasma) Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Colloids (Blood Plasma) in 2025? zhanKai

The global market size of Colloids (Blood Plasma) in 2025 was 378 Million USD.

What was the global market size of Colloids (Blood Plasma) in 2031? shouQi

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Colloids (Blood Plasma) market? shouQi

What is the annual compound growth rate of the global Colloids (Blood Plasma) market size from 2025 to 2031? shouQi

Related Reports

Global Colloids (Blood Plasma) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Colloids (Blood Plasma) market size was US$ 378 million in 2025 and is forecast to reach a readjusted size of US$ 317 million by 2032 with a CAGR of -2.5% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 114
USD 4250.00
(Single User License)
Global Colloids (Blood Plasma) Market Research Report 2026
The global Colloids (Blood Plasma) market was valued at US$ 378 million in 2025 and is anticipated to reach US$ 317 million by 2032, at a CAGR of -2.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 143
USD 2900.00
(Single User License)
Colloids (Blood Plasma)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Colloids (Blood Plasma) was estimated to be worth US$ 378 million in 2025 and is projected to reach US$ 317 million, growing at a CAGR of -2.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 167
USD 3950.00
(Single User License)
Global Colloids (Blood Plasma) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Colloids (Blood Plasma) market is projected to grow from US$ 387 million in 2024 to US$ 325 million by 2031, at a CAGR of -2.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 189
USD 4900.00
(Single User License)
Global Colloids (Blood Plasma) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Colloids (Blood Plasma) was estimated to be worth US$ 387 million and is forecast to reach approximately US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 196
USD 5900.00
(Single User License)
Global Colloids (Blood Plasma) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Colloids (Blood Plasma) market size was US$ 387 million in 2024 and is forecast to a readjusted size of US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 119
USD 4250.00
(Single User License)
Colloids (Blood Plasma)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Colloids (Blood Plasma) was estimated to be worth US$ 387 million in 2024 and is forecast to a readjusted size of US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 157
USD 3950.00
(Single User License)
Global Colloids (Blood Plasma) Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published Date: 2024-04-17
Pages: 202
USD 5600.00
(Single User License)
Global Colloids (Blood Plasma) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published Date: 2024-04-16
Pages: 192
USD 5900.00
(Single User License)
Global Colloids (Blood Plasma) Market Insights, Forecast to 2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published Date: 2024-04-07
Pages: 125
USD 4900.00
(Single User License)

Global Colloids (Blood Plasma) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Colloids (Blood Plasma) market size was US$ 378 million in 2025 and is forecast to reach a readjusted size of US$ 317 million by 2032 with a CAGR of -2.5% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 114
USD 4250.00 (Single User License)
Global Colloids (Blood Plasma) Market Research Report 2026
The global Colloids (Blood Plasma) market was valued at US$ 378 million in 2025 and is anticipated to reach US$ 317 million by 2032, at a CAGR of -2.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 143
USD 2900.00 (Single User License)
Colloids (Blood Plasma)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Colloids (Blood Plasma) was estimated to be worth US$ 378 million in 2025 and is projected to reach US$ 317 million, growing at a CAGR of -2.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 167
USD 3950.00 (Single User License)
Global Colloids (Blood Plasma) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Colloids (Blood Plasma) market is projected to grow from US$ 387 million in 2024 to US$ 325 million by 2031, at a CAGR of -2.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 189
USD 4900.00 (Single User License)
Global Colloids (Blood Plasma) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Colloids (Blood Plasma) was estimated to be worth US$ 387 million and is forecast to reach approximately US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 196
USD 5900.00 (Single User License)
Global Colloids (Blood Plasma) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Colloids (Blood Plasma) market size was US$ 387 million in 2024 and is forecast to a readjusted size of US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 119
USD 4250.00 (Single User License)
Colloids (Blood Plasma)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Colloids (Blood Plasma) was estimated to be worth US$ 387 million in 2024 and is forecast to a readjusted size of US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 157
USD 3950.00 (Single User License)
Global Colloids (Blood Plasma) Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published: 2024-04-17
Pages: 202
USD 5600.00 (Single User License)
Global Colloids (Blood Plasma) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published: 2024-04-16
Pages: 192
USD 5900.00 (Single User License)
Global Colloids (Blood Plasma) Market Insights, Forecast to 2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published: 2024-04-07
Pages: 125
USD 4900.00 (Single User License)